"I will recommend current investors to hold and advise new investors to stay away from Arena in light of limited upside and high launch uncertainty".....WOW!!!!!
They must be short or jealous they missed out. I don't care what they say at this point. We're close to the marketing of this drug and after all this, to sell? They're nuts. They have lost a lot of their credibility as years have gone by, and with all the other investment sites that individual investor can seek information. Ciao Motley Fool!
I stopped reading after this comment in the blog,
"As the chart below shows, ARNA's rise after the approval was less dramatic as compared to Vivus because Vivus's drug was the first drug to get FDA approval; the approval of Belviq caused depreciation in Vivus’s stock price."
He can't even get his facts straight. Belviq was the first to get FDA approval! What an idiot!
Why? What kind of investor would pay any attention to a Blog post on Motley Fool? It would be as foolish as basing trading decisions on something posted on this board. To drop the PPS by $1 (10%) would require millions of shares to be traded. And people who own millions of shares don't pay attention to what's on Motley Fool.
OMG! That guy said that! What Do We All Do??!! Can I sell all of my shares now on Sunday!?) OR maybe you should sell your Dec 22 2012 $9 puts and buy long into the Jan 9s or 10s, hmmm?
Sentiment: Strong Buy